Promptly at ProEmpower’s Phase 1

Promptly at ProEmpower’s Phase 1

Promptly was selected to the phase 1 of the ProEmpower, a European Project that aims to empower patients with type 2 diabetes in managing their own disease.

Promptly is a member of the winning consortium - Gnomon Informatics 

ProEmpower is a pre–commercial procurement (PCP) project to buy R&D services to improve the treatment and self-management of diabetes type 2 patients using a Personalised Diabetes Management Solution.

In total, 15 tenders were submitted, and after an evaluation process five tenders were selected to continue to Phase 1 of the project
Gnomon Informatics;
  • Linkcare;
  • Hemosoft Bilisim ve Egitim Hizmetleri;
  • Health Insight Solution;
  • Tech4Care;

ProEmpower receives funding from the European Union’s Horizon 2020 research and innovation programme and it is structured in three phases:
  • Phase 1: Concept design, solution architecture and technical specifications;
  • Phase 2: Development of prototype systems in two iterations;
  • Phase 3: Development and testing of pilot systems.


Related Link: Learn more about ProEmpower project